Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | METAP1 | P53582 | 1/20 | 0.34 |
| ▸ | MARS1 | P56192 | 4/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1345094 | 0.98 | GSR (0.47) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL5586890 | 0.93 | GSR (0.40) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Serine SCHEMBL3442575 | 0.89 | GSR (0.50) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL5617582 | 0.86 | RNPEP (0.42) | METAP2METAP1MARS1RNPEP | |
| SCHEMBL20996747 | 0.86 | RNPEP (0.42) | METAP2METAP1MARS1RNPEP | |
| SCHEMBL162031 | 0.86 | RNPEP (0.42) | METAP2METAP1MARS1RNPEP | |
| SCHEMBL6045793 | 0.86 | RNPEP (0.42) | METAP2METAP1MARS1RNPEP | |
| SCHEMBL20240364 | 0.84 | GSR (0.61) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL1404247 | 0.84 | GSR (0.61) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL344574 | 0.84 | GSR (0.61) | GSRGNAI3GNAO1GNAI1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408999-A1 | COMPOSITIONS ADDRESSING INFLAMMATION AND/OR DEGENERATIVE DISORDERS | BOMAC LABORATORIES LIMITED (NZ) | 2004-04-21 | — | — | EP | disclosed |
| WO-2001005411-A1 | COMPOSITIONS ADDRESSING INFLAMMATION AND/OR DEGENERATIVE DISORDERS | BOMAC LABORATORIES LIMITED (NZ) | 2001-01-25 | — | — | WO | disclosed |